TERZIQ

Serial Number 77346975
606

Registration Progress

Application Filed
Dec 7, 2007
Under Examination
Jan 6, 2009
Approved for Publication
Sep 24, 2008
Published for Opposition
Oct 14, 2008
Registered

Trademark Image

TERZIQ

Basic Information

Serial Number
77346975
Filing Date
December 7, 2007
Published for Opposition
October 14, 2008
Abandonment Date
February 7, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 7, 2011
Classes
005

Rights Holder

Synta Pharmaceuticals Corp.

03
Address
45 Hartwell Avenue
Lexington, MA 02421

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

Synta Pharmaceuticals Corp.

Original Applicant
03
Lexington, MA

Synta Pharmaceuticals Corp.

Owner at Publication
03
Lexington, MA

Legal Representation

Attorney
Roberta Jacobs-Meadway

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

28 events
Date Code Type Description
Feb 7, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Feb 7, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 3, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 2, 2010 EX3G S SOU EXTENSION 3 GRANTED
Jul 1, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 1, 2010 EXT3 S SOU EXTENSION 3 FILED
Feb 9, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 9, 2010 EX2G S SOU EXTENSION 2 GRANTED
Jan 6, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 6, 2010 EXT2 S SOU EXTENSION 2 FILED
Jul 6, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 6, 2009 EXT1 S SOU EXTENSION 1 FILED
Jul 6, 2009 EX1G S SOU EXTENSION 1 GRANTED
Jan 6, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 14, 2008 PUBO A PUBLISHED FOR OPPOSITION
Sep 24, 2008 NPUB O NOTICE OF PUBLICATION
Sep 8, 2008 ALIE A ASSIGNED TO LIE
Sep 8, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 28, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 27, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2008 CPRA R PRIORITY ACTION WRITTEN
Mar 28, 2008 GPRA F PRIORITY ACTION E-MAILED
Mar 28, 2008 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 26, 2008 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2008 DOCK D ASSIGNED TO EXAMINER
Dec 12, 2007 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of oncologic and inflammatory diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...